AmJ Cardiol 100:824829, 2007 [ Links ] 46
Going from $179 to $299 for semaglutide, or $279 to $399 for tirzepatide, is a significant monthly increase
Given the largely indeterminate effects of healthcare innovation on fiscal budgets and inflation but potentially significant GDP upside from GLP-1s and data-driven innovations, we expect ongoing health innovation to impact the economy most clearly through higher output
After your injection window closes, switch to smaller, frequent meals every 2-3 hours rather than three large meals daily
[Abstract] Apoptosis
Combined cyclophosphamide, fludarabine, alemtuzumab, and rituximab (CFAR), an active regimen for heavily treated patients with CLL